Metoclopramid Laropharm

Metoclopramide, the active ingredient in Metoclopramid Laropharm, is a dopamine D2 receptor antagonist presented as an oral tablet for oral use. It treats nausea, vomiting, gastroparesis and related gastrointestinal disorders in adults.

GNH USA supplies Metoclopramid Laropharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide is used to manage conditions involving nausea, vomiting and delayed gastric emptying.

- Nausea and vomiting: reduces episodes of acute and chemotherapy‑induced nausea and vomiting. - Post‑operative nausea and vomiting: prevents and treats nausea after surgical procedures. - Gastroparesis: improves gastric motility and accelerates stomach emptying. - Migraine‑associated nausea: alleviates nausea accompanying migraine attacks.

Metoclopramide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Restlessness: a sense of inner tension or inability to stay still. - Diarrhea: loose, frequent stools. - Abdominal cramps: discomfort or pain in the stomach area. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Extrapyramidal symptoms: involuntary muscle movements or rigidity. - Tardive dyskinesia: persistent, irreversible facial or tongue movements. - Neuroleptic malignant syndrome: life‑threatening fever and muscle rigidity. - Severe allergic reactions: rash, swelling, or breathing difficulty. - Hyperprolactinemia: elevated prolactin levels causing hormonal disturbances.

Before prescribing Metoclopramid Laropharm, clinicians should consider several safety factors.

- Assess renal function: dose adjustment may be required in severe renal impairment. - Monitor for extrapyramidal symptoms: especially with prolonged therapy. - Use caution in patients with depression or suicidal thoughts. - Avoid in patients with known hypersensitivity to metoclopramide. - Store at room temperature: keep in the original container, protect from moisture and light.

Metoclopramid Laropharm can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - CNS depressants (e.g., opioids, benzodiazepines): may increase sedation and respiratory depression. - Anticholinergic agents: may reduce the prokinetic effect of metoclopramide. - MAO inhibitors: risk of hypertensive crisis.

Moderate Interactions (Monitor Closely): - Antipsychotics (e.g., haloperidol): additive dopamine blockade may heighten extrapyramidal risk. - CYP2D6 substrates (e.g., codeine): altered metabolism may affect drug levels. - SSRIs/SNRIs: potential for increased serotonin syndrome risk.